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ABSTRACT
The RuvABC proteins of Escherichia coli process
recombination intermediates during genetic recom-
bination and DNA repair. RuvA and RuvB promote
branch migration of Holliday junctions, a process that
extends heteroduplex DNA. Together with RuvC, they
form a RuvABC complex capable of Holliday junction
resolution. Branch migration by RuvAB is mediated by
RuvB, a hexameric ring protein that acts as an
ATP-driven molecular pump. To gain insight into the
mechanism of branch migration, random mutations
were introduced into the ruvB gene by PCR and a
collection of mutant alleles were obtained. Mutation of
leucine 268 to serine resulted in a severe UV-sensitive
phenotype, characteristic of a ruv defect. Here, we
report a biochemical analysis of the mutant protein
RuvBL268S. Unexpectedly, the purified protein is fully
active in vitro with regard to its ATPase, DNA binding
and DNA unwinding activities. It also promotes efficient
branch migration in combination with RuvA, and forms
functional RuvABC–Holliday junction resolvase com-
plexes. These results indicate that RuvB may perform
some additional, and as yet undefined, function that is
necessary for cell survival after UV-irradiation.
INTRODUCTION
The ruvA, ruvB and ruvC genes of Escherichia coli are required
for normal levels of cellular resistance to the effects of UV- or
ionising-irradiation, or to the harmful effects of DNA-damaging
agents such as mitomycin C (1–3). ruv mutants are mildly
defective in recombination (4), and this recombination defect is
greatly enhanced by a mutation in recG (5).
Genetic studies indicate that the ruv genes are involved in a late
step of recombination and the recombinational repair of DNA
damage (6). Consistent with this, biochemical studies have shown
that the RuvA, RuvB and RuvC proteins are involved in the
processing of recombination intermediates (for review see 7).
RuvA and RuvB interact to form a complex that drives the branch
migration of Holliday junctions, a reaction that results in the
extension of heteroduplex DNA. The third Ruv protein, RuvC, is
an endonuclease that also specifically interacts with the junction,
in this case to promote its resolution into two nicked duplex
products that can be subsequently repaired by DNA ligase.
RuvAB stimulate Holliday junction resolution by RuvC (8,9),
indicating that resolution in vivo is mediated by a RuvABC
complex (10–14). The formation of specific RuvABC–Holliday
junction complexes was recently demonstrated in vitro (15).
The RuvA protein (a tetramer of four 22 kDa subunits) binds
specifically to Holliday junctions, forming stable RuvA–junction
complexes (16,17). The DNA within the complex exhibits
four-fold symmetry, with the four arms of DNA extended towards
the corners of a square (12,18,19). Two tetramers can interact
with the junction such that it becomes sandwiched between the
two concave protein faces (20,21). However, in the RuvABC
resolvase complex it is thought that the junction is bound by only
one RuvA tetramer, leaving the other face open for interaction
with RuvC (8,9,12,22).
RuvA targets RuvB protein, a hexameric ring protein, to the site
of the Holliday junction (23–27). RuvB (37 kDa) shows sequence
homology and structural similarity to a family of ring helicases
that includes E.coli DnaB protein (28), the bacteriophage T7 gp4
(29) and T4 gp41 helicases (30), and the viral SV40 T antigen
(31). In vitro, RuvB exhibits DNA helicase activity in the presence
of RuvA (32,33). When visualised by electron microscopy, RuvAB
were shown to assemble on the Holliday junction as a tripartite
complex with RuvA flanked by two hexameric rings of RuvB
(18). The rings lie across the junction from each other and are
oppositely oriented. The RuvB rings are thought to constitute an
ATP-dependent molecular pump that promotes branch migration
(26). A mutant RuvB protein (RuvBD113N) has been described
which forms hexameric rings in solution but is defective in DNA
binding and ATP-hydrolysis (34).
To better understand the molecular mechanism used by the
RuvB hexameric ring to mediate branch migration, a series of
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ruvB mutants have been obtained and selected RuvB mutant
proteins purified to homogeneity. Here, we report the generation




Escherichia coli strains HRS1004 (35) and H124 (1,36) are
derived from AB1157. HRS1004 carries a deletion of the ruvAB
operon and HI24 contains a ruvB4 mutation.
Sequence comparisons
Protein sequences of E.coli RuvB (37,38) homologues in
Haemophilus influenzae (39), Mycobacterium leprae (40),
Mycobacterium tuberculosis (40), Mycoplasma genitalium (41),
Pseudomonas aeruginosa (42), Synechocystis sp. (GenBank
accession no. U38892), Thermotoga maritima (43) and Thermus
thermophilus (43) were aligned using PileUp software
(Wisconsin Package Version 9.0, Genetics Computer Group,
Madison, WI).
Random mutagenesis
Mutations were introduced into the ruvB gene by error-prone
PCR (44). Reaction mixtures (100 µl) contained 25 mM
Taps–HCl (pH 9.3), 50 mM KCl, 1 mM dithiothreitol, 2 mM
MgCl2, 0.5 mM MnCl2, 1 mM dGTP, 1 mM dTTP, 1 mM dCTP,
0.1 mM dATP, 0.2 µM of each primer and 10 ng of template
DNA. The template was plasmid pGTI19 containing the wild-type
ruvB gene (36). Two regions of ruvB were amplified separately:
the 5′-region between 1 and 432 bp (primers: 5′-GCACTGCA-
GATGAGGTAAAGGATGATTGAAG-3′ and 5′-CGCCGGA-
CCTTCACCA-3′) and the 3′-region between 346 and 1055 bp
(primers: 5′-CACCGTCTATCGCCAGT-3′ and 5′-GGCATATT-
GCCAGTGC-3′). Taq polymerase reactions were performed at
94C for 1 min, 50C for 1 min and 70C for 4 min, for 30 cycles,
followed by 7 min at 70C. Amplified DNA was gel purified and
digested with KpnI and BbsI (for the 5′-region) or BbsI and ClaI
(for the 3′-region). DNA fragments were subcloned into pGTI19
to replace the corresponding regions of ruvB. Ligation mixtures
were then transformed into HI24 ruvB4 strain and clones were
tested for their ability/inability to restore UV resistance.
UV sensitivity
The UV sensitivities of AB1157 ruv+ and HI24 ruvB4 containing
plasmid pGTI19 (ruvB+), pME2 (ruvBL268S) or pUC19 were
measured as described (34).
Proteins and reagents
RecA (13), RuvA and RuvB (45) and wheat germ topoisomerase
I (46) were purified as described. RuvBL268S was purified from
E.coli strain HRS1004 using a modified version of the protocol
developed for the wild-type RuvB protein. In the first chromato-
graphic step, the phosphocellulose column was omitted and the
supernatant of the cell lysate was loaded directly onto a DEAE-
Biogel column. RuvBL268S eluted at a lower salt concentration
(170–220 mM KCl) than wild-type RuvB (240–270 mM KCl).
The protein was then applied to a hydroxylapatite column in
buffer containing 200 mM KCl, 10 mM potassium phosphate and
eluted with a 200 mM KCl, 10–150 mM potassium phosphate
gradient. Fractions eluting between 35 and 50 mM potassium
phosphate were pooled. RuvBL268S was then purified to homo-
geneity by Mono Q FPLC as described for wild-type RuvB.
Protein concentrations are expressed in monomers and were
determined using the Bradford assay. However, the concentrations
of RecA and RuvB (or RuvBL268S) were determined spectro-
photometrically using ε280 = 2.7 × 104 (RecA) and
1.64 × 104 M–1 cm–1 (RuvB). BSA (Gibco BRL), phosphocreatine
(Sigma), phosphocreatine kinase (Sigma), proteinase K
(Boehringer-Mannheim), glutaraldehyde (Sigma), T4 poly-
nucleotide kinase (Pharmacia), Taq polymerase (Boehringer-
Mannheim) and terminal transferase (Amersham) were purchased
as indicated. Restriction enzymes were from New England Biolabs.
DNA substrates
Form I Bluescript KS, pDEA-7Z and pAKE-7Z plasmid DNAs,
ØX174 single-stranded and form I duplex DNAs, gapped duplex
pDEA-7Z DNA (gDNA) and linearised 3′-32P-labelled
pAKE-7Z DNA were prepared as described (34).
For helicase assays, a 30 nt oligonucleotide, complementary to
the region 570–599 of ØX174 ssDNA, was 5′-32P-end-labelled
using T4 polynucleotide kinase and [γ-32P]ATP (Amersham). It
was annealed with ØX174 ssDNA as described (32) and purified
by gel filtration through a 3 ml Bio-Gel A-0.5m column
equilibrated with 10 mM Tris–HCl (pH 8.0), 1 mM EDTA and
100 mM NaCl.
Concentrations of 32P-labelled DNA substrates were determined
by calculating the specific activity using DE81 filters (47), or by
measuring the absorbance at 260 nm. Unless stated otherwise,
DNA concentrations are expressed in moles of nucleotide
residues.
DNA binding, ATPase and branch migration assays
Reactions were carried out as described (34).
DNA unwinding assay
DNA helicase reactions (20 µl) contained 1 µM annealed DNA
substrate in 50 mM Tris–HCl (pH 8.0), 15 mM MgCl2, 10 mM
NaCl, 2 mM ATP, 2 mM DTT and 100 µg/ml BSA. The DNA was
premixed with RuvA, and the reactions initiated by addition of
RuvB or RuvBL268S. After 8 min incubation at 37C, reactions
were stopped and the products deproteinised and analysed by PAGE
(32). 32P-labelled DNA was visualised by autoradiography.
The unwinding of covalently closed DNA was carried out as
described previously with a few modifications (48). Reactions
contained 20 mM Tris-acetate (pH 7.5), 10 mM Mg(OAc)2,
0.5 mM EDTA, 0.5 mM ATP, 0.5 mM ATPγS, 2 mM DTT,
100 µg/ml BSA and 60 µM form I ØX174 DNA. After addition
of RuvA (8 µM), unwinding was initiated by addition of RuvB or
RuvBL268S. After 15 min at 37C, 20 U of wheat germ
topoisomerase I, an amount sufficient to relax protein-free DNA
within 30 s, was added (48) and incubation at 37C was continued
for 5 min. The reactions were then stopped and deproteinised by
treatment with SDS (0.8%) and proteinase K (0.8 mg/ml) for
15 min at 37C. DNA products were purified by extraction with
phenol/chloroform followed by ethanol precipitation. Agarose
gel electrophoresis was carried out as described (48). Gels were
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dried on DE81 paper and then washed with distilled water. The
DNA was denatured by soaking the gel in 0.5 M NaOH, 150 mM
NaCl for 20 min and then neutralised with 0.5 M Tris–HCl
(pH 8.0), 150 mM NaCl. The DNA was hybridised with a
5′-32P-end-labelled 66mer complementary to the ØX174 DNA,
and the gel was dried and exposed to Kodak XAR films.
Holliday junction resolution
Synthetic Holliday junctions were prepared by annealing four
oligonucleotides (66 nt in length): strand 1, 5′-TATCGAATCCG-
TCTAGTCAACGCTGCCGAATTCTACCAGTGAGGATGG-
ACTCCTCACCTGCAGGTT-3′; strand 2, 5′-AACCTGCAGG-
TGAGGAGTCCATGGTCTTCCGTCAAGCTCGATGCCGG-
TTGTATGCCCACGTTGACC-3′; strand 3, 5′-GGTCAACGT-
GGGCATACAACCGGCATCGAGCTTGACGGAAGACCAT-
CCCTGTCTAGAGGATCCGAC-3′; and strand 4, 5′-GTCGG-
ATCCTCTAGACAGGGATCCTCACTGGTAGAATTCGGCA-
GCGTTGACTAGACGGATTCGATA-3′. DNA annealing and
junction purification were carried out essentially as described
previously (49). Prior to annealing, strand 1 was 5′-32P-end-
labelled using polynucleotide kinase. Concentrations of synthetic
junctions are indicated in moles of junctions.
Junctions (1 nM) were incubated with RuvC, in the presence or
absence of RuvA and RuvB, in cleavage buffer [50 mM
Tris-acetate (pH 8.0), 15 mM Mg(OAc)2, 1 mM ATPγS, 1 mM
DTT and 100 µg/ml BSA; total volume 20 µl] for 30 min at 37C.
The products were deproteinised and analysed by 8% neutral
PAGE (8).
Electron microscopy
Complexes of RuvB and RuvBL268S on pAKE-7Z linear duplex
DNA were visualised as described (34).
Immunoprecipitation
Co-immunoprecipitation experiments with RuvA, RuvB (or
RuvBL268S) and RuvC were carried out using synthetic Holliday
junction X0 as described (15). After incubation, protein–DNA
complexes were immunoprecipitated using anti-RuvC monoclonal
antibodies coupled to protein-G Sepharose beads (Pharmacia).
Complexes were analysed by SDS–PAGE followed by western
blotting with rabbit anti-RuvA, anti-RuvB and anti-RuvC polyclonal
antibodies using ECL detection (Amersham).
RESULTS AND DISCUSSION
Random mutagenesis of the cloned ruvB gene and
identification of mutants that confer UVS phenotype
Error-prone PCR (44) was used to introduce random mutations
into the cloned ruvB gene. Two different segments of ruvB were
mutated: the 5′-region between 1 and 432 bp and the 3′-region
between 346 and 1055 bp. The amplified fragments were cloned
into the high copy number plasmid pGTI19 (ruvB+), replacing the
equivalent segments of the wild-type gene. The resulting
plasmids were transformed into a UV-sensitive ruvB strain (HI24)
and clones were tested for their UV sensitivity. In total, 40 out of
1070 clones were identified as being unable to complement the
UVS phenotype. Plasmids were recovered from these clones and
tested for their ability to over-express soluble RuvB protein in
strain HRS1004, which carries a ruvAB deletion. Although many
plasmids expressed insoluble RuvB, 12 gave good over-expression
of soluble protein and for each, the entire ruvB open reading
frame was sequenced. Of these, eight plasmids were found to
contain point mutations resulting in single amino acid changes in
the RuvB protein sequence (Fig. 1). The mutants were designated
F44L, V90A, K93L, T161A, D232G, F261L, F261S and L268S
(Fig. 1).
Sequence analysis of RuvB indicates the presence of a number
of motifs that are characteristically found in DNA/RNA helicases
(50). Helicase domains I and II (two motifs involved in nucleotide
binding and hydrolysis; 51,52) and helicase motifs III and VI are
highly conserved whereas motifs IV and V are not (Fig. 1).
Surprisingly, only one of the eight mutants obtained (T161A)
contained a mutation within a helicase motif (motif III). When the
mutant RuvB proteins were purified, we observed that one,
RuvBL268S, was exceptional in that it acts as a wild-type protein in
vitro, although strains carrying it exhibit a severe UVS phenotype.
Dominant negative phenotype of RuvBL268S
Plasmid pME2, carrying the ruvBL268S gene under the control of
the plac promoter, was transformed into E.coli strains HI24 ruvB4
and AB1157 ruv+ to assess how expression of the mutant protein
affected their UV sensitivity. Due to the absence of lacIq,
RuvBL268S was expressed constitutively in both strains. As
expected, in view of the selection screen used after mutagenesis,
expression of RuvBL268S in HI24 failed to complement the ruvB4
mutation, even at low UV doses (Fig. 2A). Expression of
RuvBL268S in AB1157 resulted in a dominant negative phenotype,
such that the wild-type strain carrying pME2 became sensitive to
UV irradiation (Fig. 2A). In contrast, over-expression of wild-type
RuvB (pGTI19) in AB1157 did not affect UV sensitivity.
Purification of RuvBL268S protein
To characterise the biochemical defects associated with the
mutation in RuvBL268S, the mutant protein was over-expressed in
the ruvAB deletion strain E.coli HRS1004. The procedure used to
purify RuvBL268S was similar to the protocol developed for
wild-type RuvB. However, during its purification, we observed
that RuvBL268S eluted from DEAE-Biogel at a significantly
lower salt concentration (170–220 mM KCl) than that of
wild-type protein (240–270 mM KCl), suggesting that the L268S
mutation may have produced a change in the conformational state
of the protein. After purification, RuvBL268S protein was found to
be >95% homogeneous when analysed by SDS–PAGE (Fig. 2B).
DNA binding and ATPase activities of RuvBL268S
To determine whether RuvBL268S bound DNA, wild-type and
mutant proteins were incubated with supercoiled circular duplex
DNA in the presence of 15 mM Mg2+ and ATPγS. The resulting
protein–DNA complexes were fixed with glutaraldehyde and
analysed by agarose gel electrophoresis. The band-shift patterns
obtained with RuvB or RuvBL268S were similar, such that the
degree of DNA retardation was directly proportional to the
protein concentration until saturation was reached (Fig. 3A).
Similar results were obtained without glutaraldehyde fixation
(data not shown). Electron microscopic analysis of glutaraldehyde-
fixed complexes, formed between RuvBL268S and linear duplex
DNA, showed that the mutant protein formed double rings on
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Figure 1. Alignment of the E.coli RuvB sequence with eight homologues. Identical and similar amino acids are boxed in black and grey, respectively. DNA helicase
motifs I–VI are indicated above the alignment. The positions and the nature of the substitutions obtained by random mutagenesis are indicated. Their numbering relates
to the amino acid sequence of E.coli RuvB.
DNA (Fig. 3C) that were indistinguishable from the double
hexameric rings made by wild-type protein (Fig. 3B).
In previous studies, it was shown that RuvB exhibits a weak
affinity for DNA at low Mg2+ concentrations (≤10 mM Mg2+)
and that under these conditions its interaction with DNA requires
RuvA. Analysis of the RuvA-directed binding of RuvB or
RuvBL268S, in the presence of 5 mM Mg2+, indicated that wild-type
and mutant proteins bound with similar affinities (data not shown).
The DNA-dependent ATPase activities of RuvB and RuvBL268S
were also found to be comparable. In both cases, the amount of
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Figure 2. In vivo complementation assays and SDS–PAGE analysis of purified
RuvBL268S. (A) UV survival curves of HI24 and AB1157 following
transformation with plasmids pME2 (ruvBL268S, ∆), pGTI19 (ruvB+, ) or
pUC19 ( ). (B) SDS–PAGE of RuvB and RuvBL268S proteins. Proteins (3 µg)
were analysed on a 10% polyacrylamide gel and visualised by staining with
Coomassie Blue. The positions of the molecular mass markers are indicated.
Figure 3. Duplex DNA binding by RuvB and RuvBL268S. (A) DNA binding
assays were carried out as described in Materials and Methods using the
indicated concentrations of RuvB or RuvBL268S. (B and C) Electron
microscopic visualisation of RuvB and RuvBL268S, respectively, in the
presence of linear duplex DNA.
ATP hydrolysed in a given time was proportional to protein
concentration (Fig. 4A). In the absence of RuvA, rates of
hydrolysis in the order of 4 mol ATP/min/mol RuvB were
observed (Fig. 4B). The rates of hydrolysis catalysed by RuvB or
RuvBL268S were stimulated to the same extent by the presence of
RuvA (Fig. 4B). These results indicate that the DNA binding and
DNA-dependent ATPase activities of RuvB and RuvBL268S are
indistinguishable and that both proteins interact with RuvA.
DNA unwinding properties of RuvBL268S
Two assays were used to determine whether RuvBL268S possessed
the ability to promote DNA unwinding. First, we analysed its
Figure 4. ATPase activity of RuvBL268S compared to wild-type RuvB.
(A) ATPase activity analysed as a function of protein concentration. Reactions
contained the indicated concentrations of RuvB () or RuvBL268S () and
were carried out as described in Materials and Methods. Incubation was for
20 min at 37C. (B) Effect of RuvA on RuvB- or RuvBL268S-mediated ATP
hydrolysis. Large scale reactions (100 µl) contained either RuvB (3 µM) with
(n ) or without () RuvA, or RuvBL268S with ( l ) or without () RuvA. RuvA
(1 µM) was added to the preincubation mixtures immediately before initiation.
Aliquots were taken at the indicated times and the percentage of ATP
hydrolysed was determined. Background levels of ADP (∼3%) have been
subtracted.
activity in a DNA helicase assay, which measured the displacement
of a short (30 nt) 32P-labelled oligonucleotide annealed to circular
single-stranded DNA (32). In the presence of RuvA, we observed
that RuvBL268S displaced the 30mer with the same efficiency as
wild-type RuvB (Fig. 5A, compare lanes c–f with h–k). Secondly,
we used a sensitive topological assay to measure protein-induced
DNA underwinding (48). In this assay, the underwinding of
covalently closed duplex DNA by RuvAB results in the
introduction of positive superhelical turns that are removed by
eukaryotic topoisomerase I. Upon deproteinisation, the under-
wound DNA is observed after agarose gel electrophoresis as
moderately negatively supercoiled DNA (Fig. 5B, lane h). In
contrast, DNA that has not been underwound is seen at the
position of relaxed DNA (lane b). With both wild-type RuvB and
RuvBL268S, we found that the degree of unwinding was directly
proportional to the protein concentration (compare lanes d–h with
i–m). We conclude that RuvBL268S fails to exhibit any defect in
its ability to promote DNA unwinding.
Effect of RuvBL268S on RuvB- and RuvAB-mediated
branch migration
Using 32P-labelled recombination intermediates (α-structures) pre-
pared by RecA-mediated strand exchange reactions (13) between
gapped circular pDEA-7Z plasmid DNA and 32P-labelled PstI
linearised duplex pAKE-7Z DNA which contains a heterologous
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Figure 5. DNA unwinding activity of RuvBL268S compared to wild-type
RuvB. (A) Displacement of a 30 nt fragment annealed to circular single-
stranded DNA. Reactions were carried out as described in Materials and
Methods, using the indicated amounts of RuvA and RuvB/RuvBL268S.
Products were analysed by 8% PAGE. Lane m, control in which the DNA was
heat-denatured at 100C for 3 min prior to loading. (B) Unwinding of circular
duplex DNA. Assays were carried out as described in Materials and Methods
using the indicated concentrations of RuvA and RuvB proteins. Topoisomerase
was added where indicated. DNA products were deproteinised and analysed on
a 1% agarose gel.
block, we observed that wild-type RuvB catalysed branch
migration to produce 32P-labelled linear duplex products
(Fig. 6A, lanes b–g). As shown previously (24,53), the wild-type
protein promoted branch migration in the absence of RuvA with
an efficiency directly proportional to its concentration. Under the
same conditions, similar results were obtained with RuvBL268S
(lanes h–m).
Branch migration experiments were also carried out in the
presence of RuvA. Because RuvA promotes the specific targeting
of RuvB to the Holliday junction, these experiments were
performed at low RuvB concentrations. RuvBL268S was found to
promote efficient branch migration, such that >90% of the
recombination intermediates were processed into branch migration
products (Fig. 6B). In a series of experiments, the efficiency of
branch migration by RuvBL268S and wild-type RuvB were
compared over a range of protein concentrations. The two
proteins were found to promote branch migration with similar
efficiencies (data not shown).
RuvABC complex formation
Since RuvBL268S failed to show any obvious defect in its ability
to promote branch migration, we next tested to see whether it was
capable of forming functionally-active RuvABC complexes. First,
we used immunoprecipitation assays to analyse whether RuvBL268S
was able to form RuvABC–Holliday junction complexes in vitro
Figure 6. Branch migration activities of RuvB and RuvBL268S. (A) 32P-labelled
recombination intermediates were incubated with the indicated concentrations
of RuvB or RuvBL268S. Reactions were stopped and DNA products were
visualised by agarose gel electrophoresis followed by autoradiography.
(B) Assays were carried out as in (A), except that RuvA (30 nM) was added
immediately before RuvB or RuvBL268S.
(Fig. 7A), and secondly, we tested whether RuvBL268S was
capable of stimulating Holliday junction resolution catalysed by
the RuvC protein (Fig. 7B).
Immunoprecipitation experiments were carried out by mixing
RuvA, RuvBL268S (or RuvB as a control) and RuvC with
Holliday junction DNA, and the resulting complexes were
immunoprecipitated using monoclonal antibodies (MAbs) raised
against RuvC (15). As shown in Figure 7A, the anti-RuvC MAbs
pulled down a complex that contained all three Ruv proteins.
Similar results were obtained using either RuvB or mutant
RuvBL268S.
The efficiency of Holliday junction resolution by RuvC
(Fig. 7B, lane b) can be stimulated by the presence of RuvB
(lane c), or more efficiently by RuvAB (lane d). Stimulation is
thought to involve formation of a functional RuvABC–Holliday
junction resolvase complex (8,9). When reactions were carried
out using RuvBL268S, we found that the mutant protein stimulated
RuvC-mediated Holliday junction resolution (lanes f and g). The
sites of RuvC-mediated resolution were essentially the same in
the presence of RuvB or RuvBL268S (data not shown). RuvBL268S
was also found to stimulate the resolution of supercoiled figure-8
DNA molecules containing Holliday junctions (data not shown).
We conclude that RuvBL268S forms RuvABC–junction complexes
and that these complexes exhibit normal resolution activities in
vitro.
Conclusions
In this paper we have described the isolation of a mutant ruvB
allele that encodes a protein, RuvBL268S, which exhibits wild-
type RuvB activities in vitro. The ruvBL268S mutation results in
a substitution of an aliphatic amino acid (leucine 268) for a polar
amino acid (serine) positioned between the poorly-conserved
1281
Nucleic Acids Research, 1994, Vol. 22, No. 1Nucleic Acids Research, 1999, Vol. 27, No. 5 1281
Figure 7. Formation of functional RuvABC complexes by RuvBL268S.
(A) Co-immunoprecipitation of RuvABC–Holliday junction complexes using
wild-type RuvB or RuvBL268S, as indicated. Complexes were prepared and pulled
down using anti-RuvC MAbs as described in Materials and Methods. Aliquots
were analysed by SDS–PAGE and the gels were immunoblotted with a mixture
of anti-RuvA and anti-RuvB polyclonal antibodies (upper panel) or anti-RuvC
antibodies (lower panel). Proteins were detected by ECL. (B) Stimulation of
RuvC-mediated Holliday junction resolution by RuvAB or RuvABL268S.
Resolution reactions contained 32P-labelled synthetic Holliday junctions and
were carried out as described in Materials and Methods using RuvA, RuvB and
RuvC as indicated. Resolution products (32P-labelled nicked duplex DNA)
were analysed by 8% neutral PAGE and visualised by autoradiography.
helicase domain V and the well-conserved helicase domain VI. In
eight out of the nine RuvB sequences shown in the alignment in
Figure 1, an aliphatic amino acid is found at position 268. The
surrounding amino acids are relatively well-conserved, with 66%
similarity in the 57 amino acids between the helicase domains V
and VI. Since no crystallographic data are available with RuvB,
the structure and function of this region is presently unknown.
Although RuvBL268S exhibits wild-type biochemical activities
in vitro with regard to DNA binding, ATPase activity, ring
formation, DNA unwinding, branch migration and ability to form
functional RuvABC–Holliday junction complexes, the L268S
substitution has a dramatic effect in vivo. Indeed, the ruvBL268S
allele was unable to complement the ruvB4 mutation, and
over-expression of RuvBL268S exerted a dominant negative effect
in wild-type cells. Since associations between mutant (RuvBD113N)
and wild-type RuvB proteins have been observed previously (34),
it is possible that RuvBL268S interacts with wild-type RuvB to
form a hetero-hexamer that is inactive for some critical RuvB
function.
Although RuvBL268S appeared normal when assayed in vitro,
during its purification RuvBL268S eluted from the DEAE-Biogel
column at lower salt concentrations than the wild-type protein,
suggesting that the mutation caused a conformational change that
might affect protein–protein or protein–DNA interactions. Since
we have not observed any defects in self-association of the RuvB
hexamer, interactions with RuvA or RuvC, nor assembly of the
RuvABC–Holliday junction complex, one possibility to be
considered is that RuvB associates with some other protein in
E.coli and that leu268 is critical for this interaction.
Alternatively, subtle changes in the way that RuvBL268S
interacts with RuvA and/or RuvC, may lead to the observed
cellular defect. Because our extensive in vitro analysis of
RuvBL268S failed to identify the biochemical defect in this
protein, the data expose the limitations of such in vitro assays
which, by their necessary simplicity, can only partially reproduce
the complexity of reactions that take place in vivo. For example,
recombination intermediates made in vitro by RecA are naked,
relaxed DNA molecules that possess free ends, whereas the
natural substrates for RuvABC are likely to be supercoiled and
have many associated proteins. Indeed, target DNAs may be
actively undergoing DNA replication, transcription and repair,
and it is possible that RuvBL268S is unable to act within the
context of a DNA processing machine.
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